NCT00008515View on ClinicalTrials.gov

Fluocinolone Implant to Treat Macular Degeneration

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 31, 2001

Study Completion Date

December 31, 2001

Conditions
Choroidal NeovascularizationMacular Degeneration
Interventions
DRUG

Fluocinolone

Trial Locations (1)

20892

National Eye Institute (NEI), Bethesda

All Listed Sponsors
lead

National Eye Institute (NEI)

NIH

NCT00008515 - Fluocinolone Implant to Treat Macular Degeneration | Biotech Hunter | Biotech Hunter